Skip to main content
BANDARAM PHARMA PACKTECH LIMITED logo

BANDARAM PHARMA PACKTECH LIMITED — Investor Relations & Filings

Ticker · 524602 ISIN · INE875N01036 LEI · 335800AI1TXYK2N8H496 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS 524602

About BANDARAM PHARMA PACKTECH LIMITED

https://www.bandaram.com

Bandaram Pharma Packtech Limited specializes in the manufacturing and distribution of primary packaging solutions. The company provides a comprehensive range of products, including glass vials, ampoules, rubber stoppers, and aluminum seals designed to meet stringent regulatory standards. Its operations focus on ensuring the integrity and safety of medicinal products through high-quality materials and precision engineering. By leveraging advanced manufacturing processes, the firm serves a diverse clientele ranging from large-scale manufacturers to specialized biotechnology entities. The company emphasizes technical excellence and reliability in its supply chain, offering customized packaging configurations to address the specific stability and storage requirements of various therapeutic formulations.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for FY ended 31.03.2026
Regulatory Filings Classification · 85% confidence The document is titled “Annual Secretarial Compliance Report for the year ended March 31, 2026” submitted under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a compliance report filed with the stock exchange, detailing statutory and regulatory adherence. It does not contain financial statements typical of an Annual or Interim Report, nor is it an announcement of corporate actions like dividends, board changes, or M&A. This is a regulatory compliance filing, fitting the “Regulatory Filings” category (RNS).
2026-05-26 English
Bandaram Pharma Packtech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Audited Financial ....
Regulatory Filings Classification · 85% confidence The document is an official intimation under SEBI Listing Regulations notifying the exchange of a forthcoming Board Meeting date and agenda. It does not contain financial statements itself nor report on outcomes, nor is it a management change or AGM materials. It is a routine regulatory announcement. Therefore it falls under the catch-all Regulatory Filings category (RNS).
2026-05-21 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.